Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HeliMeds vs Klinic

HeliMeds
Graded #154

Higher grade

vs+7.5
Klinic
Graded #313

Lower grade

The verdict

HeliMeds takes it — 68.3/100 to 60.8/100.

HeliMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HeliMeds offers compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHeliMeds +29
74
45
Dose & formulationHeliMeds +24
77
53
Clinical oversightKlinic +8
71
79
Labs & monitoringKlinic +12
52
64
FulfillmentKlinic +9
67
76
Contract termsEven
55
55
HeliMeds · left barKlinic · right bar

The numbers

MetricHeliMedsKlinic
WeighScore68.3/10060.8/100
GradeCC
Scorecard rank#154#313
Semaglutide$1,599/mo (brand Wegovy)Not disclosed
Tirzepatide$149/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
HeliMeds

Graded #154 · C

Strengths

  • Both compounded and brand-name GLP-1 options available
  • LegitScript certified (#368688)
  • Compounded semaglutide from $99 — competitive pricing

Where it loses points

  • State availability not publicly disclosed
  • Compounded medications are not FDA-approved (stated on site)
  • Also a broader health platform (sexual health, energy)
Klinic

Graded #313 · C

Strengths

  • LegitScript certified, licensed in all 50 states, DEA registered, HIPAA/SOC 2 Type II compliant
  • Broad insurance acceptance including Medicare, Medicaid, BCBS, Aetna, Cigna, UHC, and Humana
  • Klinic handles all prior authorization—patient never manages PA paperwork
  • Brand-name FDA-approved GLP-1s (Wegovy, Zepbound) at full clinical doses with home delivery
  • Named clinical leadership (CMO Dr. Saba Haq, Chief Physician Dr. Vivek Chander) and disclosed founder

Where it loses points

  • Brand-name meds are costly self-pay: Wegovy ~$499/month, Zepbound ~$299/month (med cost alone; consult extra)
  • No compounded semaglutide or tirzepatide option for patients seeking lower-cost alternatives
  • Medication cost is separate from visit fees ($99 initial, $75 follow-up) — total self-pay cost is higher
  • No labs or dedicated nutrition/coaching program included in any plan
  • Pharmacy fulfillment via Klinic Pharmacy Hub Services LLC (non-dispensing hub); actual dispensing is third-party

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard